Author Question: What are the organisms typically at the bottom of the food chain or at trophic level 1? A. humans ... (Read 188 times)

rmenurse

  • Hero Member
  • *****
  • Posts: 513
What are the organisms typically at the bottom of the food chain or at trophic level 1?
 
  A. humans
  B. fauna
  C. flora
  D. microbes and plankton
  E. grasses

Question 2

In which biogeochemical cycle is the namesake element deposited in rock and exists as a gas where it influences the greenhouse effect?
 
  A. nitrogen cycle
  B. oxygen cycle
  C. carbon cycle
  D. water cycle
  E. rock cycle



lolol

  • Sr. Member
  • ****
  • Posts: 330
Answer to Question 1

D

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Illness; diuretics; laxative abuse; hot weather; exercise; sweating; caffeine; alcoholic beverages; starvation diets; inadequate carbohydrate consumption; and diets high in protein, salt, or fiber can cause people to become dehydrated.

Did you know?

People often find it difficult to accept the idea that bacteria can be beneficial and improve health. Lactic acid bacteria are good, and when eaten, these bacteria improve health and increase longevity. These bacteria included in foods such as yogurt.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library